{"id":100046,"date":"2025-04-28T13:18:06","date_gmt":"2025-04-28T13:18:06","guid":{"rendered":"https:\/\/www.mymsd.ch\/fr\/?page_id=100046"},"modified":"2026-02-04T10:07:10","modified_gmt":"2026-02-04T10:07:10","slug":"prevymis","status":"publish","type":"page","link":"https:\/\/www.mymsd.ch\/fr\/succinctstatement\/prevymis\/","title":{"rendered":"Information professionnelle abr\u00e9g\u00e9e de PREVYMIS\u00ae"},"content":{"rendered":"\n<h1 class=\"wp-block-heading has-border-color has-has-red-border-color-border-color has-teal-500-color has-text-color  mhh-mcn-v1-heading mhh-mcn-v1-heading--f45ba4b609ae33e866270902a600966a\">Information professionnelle abr\u00e9g\u00e9e de PREVYMIS\u00ae (letermovir)<\/h1>\n\n\n\n<p class=\"has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--5116bcd6c9b7f22f91842def37c86aa6\"><strong>PREVYMIS\u00ae: PA: <\/strong>letermovir. <strong>I:<\/strong> <em>Adultes:<\/em> prophylaxie des infections \u00e0 cytom\u00e9galovirus (CMV) ou de la maladie \u00e0 CMV chez les adultes s\u00e9ropositifs au CMV receveurs [R+] d\u2019une greffe allog\u00e9nique de cellules souches h\u00e9matopo\u00ef\u00e9tiques (GCSH). <strong>Po:<\/strong><em> Adultes:<\/em> 480 mg une fois par jour, par voie orale ou intraveineuse. Commencer au plus tard 28 jours apr\u00e8s la GCSH et poursuivre jusqu\u2019\u00e0 un maximum de 200 jours apr\u00e8s celle-ci. Prevymis est disponible en trois formes pharmaceutiques: comprim\u00e9s pellicul\u00e9s, granul\u00e9s en sachet (orale, m\u00e9lang\u00e9s \u00e0 un aliment mou ou via sonde nasogastrique ou sonde gas-trique), solution \u00e0 diluer pour perfusion. Utiliser la solution \u00e0 perfuser uniquement si le traitement par voie orale n\u2019est pas possible. Diluer le concentr\u00e9 avant administration et administrer la totalit\u00e9 de la solution en perfusion i.v. lente sur 60 minutes. Pour perfusion i.v. uniquement \u00e0 travers un filtre en ligne st\u00e9rile de 0,2 ou 0,22 \u03bcm en poly\u00e9thersulfone (PES). Ne pas administrer en injection rapide ou en bolus. Si co-administr\u00e9 avec ciclosporine, r\u00e9duire Prevymis \u00e0 240 mg une fois par jour. <strong><em>Pour d&rsquo;autres indications et les dosages correspondants pour les adultes et les patients p\u00e9diatriques, veuillez-vous r\u00e9f\u00e9rer \u00e0 l&rsquo;information professionnelle. <\/em>CI: <\/strong>Hypersensibilit\u00e9 au letermovir ou \u00e0 l\u2019un des excipients, administration conco-mitante de pimozide, d\u2019alcalo\u00efdes de l\u2019ergot de seigle, de millepertuis (<em>Hypericum perforatum<\/em>) ou administration concomi-tante de ciclosporine en combinaison avec le dabigatran, atorvastatine, simvastatine, rosuvastatine, pitavastatine. <strong>Pr:<\/strong> La s\u00e9curit\u00e9 d\u2019emploi et l\u2019efficacit\u00e9 du letermovir ont \u00e9t\u00e9 \u00e9tablies chez des patients pr\u00e9sentant un r\u00e9sultat n\u00e9gatif au test ADN du CMV avant initiation de la prophylaxie. L\u2019ADN du CMV a \u00e9t\u00e9 surveill\u00e9 chaque semaine jusqu\u2019\u00e0 la Semaine 14 post-greffe, et ensuite toutes les 2 semaines jusqu\u2019\u00e0 la Semaine 24. Non recommand\u00e9 en cas d\u2019insuffisance h\u00e9patique mod\u00e9r\u00e9e associ\u00e9e \u00e0 une insuffisance r\u00e9nale mod\u00e9r\u00e9e ou s\u00e9v\u00e8re, en cas d\u2019insuffisance h\u00e9patique s\u00e9v\u00e8re (Child-Pugh classe C), en cas d\u2019insuffisance r\u00e9nale terminale (ClCr &lt;10 ml\/min) ou chez les patients dialys\u00e9s. Risque en lien avec l\u2019excipient hydroxypro-pylbetadex dans formulation intraveineuse. Risque d\u2019effets ind\u00e9sirables ou de diminution de l\u2019effet th\u00e9rapeutique du fait des interactions m\u00e9dicamenteuses. <strong>IA: <\/strong>L\u2019association de la ciclosporine et du letermovir peut conduire \u00e0 des effets plus marqu\u00e9s ou additionnels sur les m\u00e9dicaments concomitants par rapport au letermovir seul. La co-administration de PRE-VYMIS\u00ae avec des inducteurs puissants et mod\u00e9r\u00e9s des transporteurs (p.ex. P-gp) et\/ou des enzymes (p.ex. UGTs) n\u2019est pas recommand\u00e9e car elle peut conduire \u00e0 une exposition subth\u00e9rapeutique au letermovir. Le letermovir est un inhibiteur des transporteurs OATP1B1\/3 et peut provoquer une augmentation cliniquement pertinente des concentrations plasmatiques des m\u00e9dicaments co-administr\u00e9s qui sont des substrats des OATP1B1\/3. L\u2019administration concomitante de PREVYMIS\u00ae avec des inhibiteurs des transporteurs OATP1B1\/3 peut entra\u00eener des concentrations plasmatiques augment\u00e9es de leter-movir. Le letermovir est un inducteur mod\u00e9r\u00e9 des enzymes et des transporteurs. Cette induction peut entra\u00eener une r\u00e9-duction des concentrations plasmatiques de certains m\u00e9dicaments m\u00e9tabolis\u00e9s et transport\u00e9s. Le letermovir est un inhi-biteur mod\u00e9r\u00e9 du CYP3A : PREVYMIS\u00ae peut provoquer des augmentations cliniquement pertinentes des concentrations plasmatiques des substrats du CYP3A administr\u00e9s simultan\u00e9ment. Le letermovir peut potentiellement diminuer l\u2019exposition des substrats du CYP2C9 et\/ou du CYP2C19, pouvant entra\u00eener des concentrations subth\u00e9rapeutiques. Le letermovir est un inducteur de la P-gp intestinale : L\u2019administration de PREVYMIS\u00ae peut entra\u00eener une diminution clini-quement pertinente des concentrations plasmatiques des m\u00e9dicaments co-administr\u00e9s qui sont significativement trans-port\u00e9s par la P-gp dans les intestins. PREVYMIS\u00ae doit \u00eatre utilis\u00e9 avec prudence en association avec des m\u00e9dicaments m\u00e9-tabolis\u00e9s par les CYP2B6, CYP2C8, UGT1A1 ou transport\u00e9s par la BCRP, l\u2019OATP2B1 ou par le transporteur r\u00e9nal OAT3. <strong>G\/A:<\/strong> Grossesse: d\u00e9conseill\u00e9e; ne pas allaiter.<strong> EI:<\/strong> <em>Fr\u00e9quents: <\/em>naus\u00e9es, diarrh\u00e9e, vomissements. <strong>P: <\/strong><em>Comprim\u00e9s pellicul\u00e9s: <\/em>28 comprim\u00e9s \u00e0 240 mg ou 480 mg; <em>granul\u00e9s en sachet: <\/em>30 sachets \u00e0 20 mg ou 120 mg; <em>flacons de solution pour perfusion:<\/em> 240 mg \/ 12 ml; 480 mg \/ 24 ml. <strong>CR:<\/strong> A. <strong>Td\u2019A:<\/strong> MSD Merck Sharp &amp; Dohme AG, Werftestrasse 4, Lucerne, Suisse; (V6.0); CH-CYT-00006.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-gray-300-color has-alpha-channel-opacity has-gray-300-background-color has-background\" \/>\n\n\n\n<p class=\"has-object-object-font-size has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--67c099ca030642396e1796a11fd7d9da\"><em>Avant de prescrire, veuillez consulter l\u2019information professionnelle compl\u00e8te publi\u00e9e sur la page d\u2019accueil de Swissmedic (<a href=\"https:\/\/www.swissmedicinfo-pro.ch\/ShowText.aspx?textType=FI&amp;lang=FR&amp;authNr=69867\" target=\"_blank\" rel=\"noreferrer noopener\">www.swissmedicinfo-pro.ch<\/a>).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Information professionnelle abr\u00e9g\u00e9e de PREVYMIS\u00ae (letermovir) PREVYMIS\u00ae: PA: letermovir. I: Adultes: prophylaxie des infections \u00e0 cytom\u00e9galovirus (CMV) ou de la [&hellip;]<\/p>\n","protected":false},"author":73172,"featured_media":0,"parent":96214,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_mhh_sticky_footer_settings":{"entityId":0},"_mhh_sticky_footer_posts":"","_mhh_sticky_footer_expanded":false,"_mhh_mcn_text_direction":"","_mhh_mcn_language":"","_mhh_mcn_left_sidebar_settings":{"entityId":0},"_mhh_mcn_sidebar_settings":{"entityId":0},"mhh_mcn_side_navigation_style":{"fontSize":{"l":"","m":"","s":""},"lineHeight":{"l":1.5,"m":1.5,"s":1.5},"itemColor":"","hoverItemColor":"","currentItemColor":"","borderItemColor":"","backgroundItemHoverColor":"","themeColor":""},"_mhh_mcn_child_page_navigation":{"isActive":false,"isSticky":false},"hide_header":false,"show_top_bar":false,"hide_footer":false,"full_width_layout":false,"icon":null,"job_code":"","primary_tag":1608,"editor_notices":[],"mconnectHideShareThis":false,"footnotes":"","mconnectIsArchiveTemplate":false,"mconnectArchiveFiltersDisabled":false,"mconnectArchiveLockAllPresetFilters":false,"mconnectArchiveHidePageSubmenu":false,"mconnectArchiveShowParentPageOnly":false,"mconnectArchiveDefaultOrder":"DESC","mconnectArchiveDefaultOrderBy":"date","mconnectArchivePostsPerPage":12,"mconnectArchivePostTypes":[],"mconnectArchiveAllowFilterBy":["category","tx-content-type","tx-product","tx-pathology","tx-active-ingredient","tx-therapeutic-area"],"mconnectArchiveTaxonomyOrder":[],"mconnectArchiveFilterSorting":["active","is_keyword","is_date"],"mconnectArchiveContentItemStyle":{"showExcerpt":true,"showImage":true,"showIcon":false,"showPrimaryTag":true,"showBorder":false,"showDates":false,"showCta":true,"isCard":false,"hasBackground":false,"showMetadata":true},"mconnectArchiveLayout":{"type":"list","hasFeatured":false},"mconnectDynamicTaxonomyEntities":[],"mconnectArchiveTerms_category":[],"mconnectArchiveAllowTerms_category":[],"mconnectArchiveTerms_tx-content-type":[],"mconnectArchiveAllowTerms_tx-content-type":[],"mconnectArchiveTerms_tx-product":[],"mconnectArchiveAllowTerms_tx-product":[],"mconnectArchiveTerms_tx-pathology":[],"mconnectArchiveAllowTerms_tx-pathology":[],"mconnectArchiveTerms_tx-active-ingredient":[],"mconnectArchiveAllowTerms_tx-active-ingredient":[],"mconnectArchiveTerms_tx-therapeutic-area":[],"mconnectArchiveAllowTerms_tx-therapeutic-area":[],"mconnectArchiveAllowTerms_dynamic-taxonomy":[],"mconnectArchiveLegacyDefaultTermsApplied":false,"mconnectContentUpdatesPerPage":10,"mconnectContentUpdatesViewMoreUrl":"","mconnectContentUpdatesTerms_tx-content-type":[],"mconnectContentUpdatesTerms_tx-product":[],"mconnectContentUpdatesTerms_tx-pathology":[],"mconnectContentUpdatesTerms_tx-active-ingredient":[],"mconnectContentUpdatesTerms_tx-therapeutic-area":[],"sidebar_toogle":0,"sidebar_toogle_notification_warning":true,"sidebar_toogle_notification_alert":true,"content_expiration_sidebar_date":"","content_expiration_sidebar_expired_post_status":"","content_expiration_sidebar_redirection":""},"categories":[1607],"tags":[1608],"ga4_page_audience":[],"ga4_page_birn_id":[],"ga4_page_branding":[957],"ga4_page_businessunit":[965],"ga4_page_campaign":[],"ga4_page_content_purpose":[1535],"ga4_page_customer_journey_stage":[],"ga4_page_customer_specialty":[],"ga4_page_experience":[],"ga4_page_indication":[],"ga4_page_material_intent":[1206],"ga4_page_product":[1230],"ga4_page_region":[1462],"ga4_page_therapeuticarea":[1520],"tx-therapeutic-area":[658],"tx-product":[639],"tx-pathology":[],"tx-content-type":[1609],"tx-active-ingredient":[],"access":[],"user_status":[],"user_role":[],"class_list":["post-100046","page","type-page","status-publish","hentry","category-kfi","tag-kfi"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Information professionnelle abr\u00e9g\u00e9e de PREVYMIS\u00ae - MyMSD.ch FR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mymsd.ch\/fr\/succinctstatement\/prevymis\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Information professionnelle abr\u00e9g\u00e9e de PREVYMIS\u00ae - MyMSD.ch FR\" \/>\n<meta property=\"og:description\" content=\"Information professionnelle abr\u00e9g\u00e9e de PREVYMIS\u00ae (letermovir) PREVYMIS\u00ae: PA: letermovir. I: Adultes: prophylaxie des infections \u00e0 cytom\u00e9galovirus (CMV) ou de la [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mymsd.ch\/fr\/succinctstatement\/prevymis\/\" \/>\n<meta property=\"og:site_name\" content=\"MyMSD.ch FR\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-04T10:07:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/03\/02852_MSD_Logo_W-Anthem_Vertical_TealGrey_RGB.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2186\" \/>\n\t<meta property=\"og:image:height\" content=\"2134\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/succinctstatement\/prevymis\/\",\"url\":\"https:\/\/www.mymsd.ch\/fr\/succinctstatement\/prevymis\/\",\"name\":\"Information professionnelle abr\u00e9g\u00e9e de PREVYMIS\u00ae - MyMSD.ch FR\",\"isPartOf\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#website\"},\"datePublished\":\"2025-04-28T13:18:06+00:00\",\"dateModified\":\"2026-02-04T10:07:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/succinctstatement\/prevymis\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mymsd.ch\/fr\/succinctstatement\/prevymis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/succinctstatement\/prevymis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mymsd.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Product Succinct Statement\",\"item\":\"https:\/\/www.mymsd.ch\/fr\/succinctstatement\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Information professionnelle abr\u00e9g\u00e9e de PREVYMIS\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#website\",\"url\":\"https:\/\/www.mymsd.ch\/fr\/\",\"name\":\"MyMSD.ch FR\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mymsd.ch\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#organization\",\"name\":\"MSD Switzerland\",\"url\":\"https:\/\/www.mymsd.ch\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2023\/10\/cropped-myMSD-logo.png\",\"contentUrl\":\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2023\/10\/cropped-myMSD-logo.png\",\"width\":4084,\"height\":692,\"caption\":\"MSD Switzerland\"},\"image\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Information professionnelle abr\u00e9g\u00e9e de PREVYMIS\u00ae - MyMSD.ch FR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mymsd.ch\/fr\/succinctstatement\/prevymis\/","og_locale":"fr_FR","og_type":"article","og_title":"Information professionnelle abr\u00e9g\u00e9e de PREVYMIS\u00ae - MyMSD.ch FR","og_description":"Information professionnelle abr\u00e9g\u00e9e de PREVYMIS\u00ae (letermovir) PREVYMIS\u00ae: PA: letermovir. I: Adultes: prophylaxie des infections \u00e0 cytom\u00e9galovirus (CMV) ou de la [&hellip;]","og_url":"https:\/\/www.mymsd.ch\/fr\/succinctstatement\/prevymis\/","og_site_name":"MyMSD.ch FR","article_modified_time":"2026-02-04T10:07:10+00:00","og_image":[{"width":2186,"height":2134,"url":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/03\/02852_MSD_Logo_W-Anthem_Vertical_TealGrey_RGB.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mymsd.ch\/fr\/succinctstatement\/prevymis\/","url":"https:\/\/www.mymsd.ch\/fr\/succinctstatement\/prevymis\/","name":"Information professionnelle abr\u00e9g\u00e9e de PREVYMIS\u00ae - MyMSD.ch FR","isPartOf":{"@id":"https:\/\/www.mymsd.ch\/fr\/#website"},"datePublished":"2025-04-28T13:18:06+00:00","dateModified":"2026-02-04T10:07:10+00:00","breadcrumb":{"@id":"https:\/\/www.mymsd.ch\/fr\/succinctstatement\/prevymis\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mymsd.ch\/fr\/succinctstatement\/prevymis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.mymsd.ch\/fr\/succinctstatement\/prevymis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mymsd.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Product Succinct Statement","item":"https:\/\/www.mymsd.ch\/fr\/succinctstatement\/"},{"@type":"ListItem","position":3,"name":"Information professionnelle abr\u00e9g\u00e9e de PREVYMIS\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/www.mymsd.ch\/fr\/#website","url":"https:\/\/www.mymsd.ch\/fr\/","name":"MyMSD.ch FR","description":"","publisher":{"@id":"https:\/\/www.mymsd.ch\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mymsd.ch\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.mymsd.ch\/fr\/#organization","name":"MSD Switzerland","url":"https:\/\/www.mymsd.ch\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.mymsd.ch\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2023\/10\/cropped-myMSD-logo.png","contentUrl":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2023\/10\/cropped-myMSD-logo.png","width":4084,"height":692,"caption":"MSD Switzerland"},"image":{"@id":"https:\/\/www.mymsd.ch\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/pages\/100046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/users\/73172"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/comments?post=100046"}],"version-history":[{"count":15,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/pages\/100046\/revisions"}],"predecessor-version":[{"id":103251,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/pages\/100046\/revisions\/103251"}],"up":[{"embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/pages\/96214"}],"wp:attachment":[{"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/media?parent=100046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/categories?post=100046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tags?post=100046"},{"taxonomy":"ga4_page_audience","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_audience?post=100046"},{"taxonomy":"ga4_page_birn_id","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_birn_id?post=100046"},{"taxonomy":"ga4_page_branding","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_branding?post=100046"},{"taxonomy":"ga4_page_businessunit","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_businessunit?post=100046"},{"taxonomy":"ga4_page_campaign","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_campaign?post=100046"},{"taxonomy":"ga4_page_content_purpose","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_content_purpose?post=100046"},{"taxonomy":"ga4_page_customer_journey_stage","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_customer_journey_stage?post=100046"},{"taxonomy":"ga4_page_customer_specialty","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_customer_specialty?post=100046"},{"taxonomy":"ga4_page_experience","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_experience?post=100046"},{"taxonomy":"ga4_page_indication","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_indication?post=100046"},{"taxonomy":"ga4_page_material_intent","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_material_intent?post=100046"},{"taxonomy":"ga4_page_product","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_product?post=100046"},{"taxonomy":"ga4_page_region","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_region?post=100046"},{"taxonomy":"ga4_page_therapeuticarea","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_therapeuticarea?post=100046"},{"taxonomy":"tx-therapeutic-area","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-therapeutic-area?post=100046"},{"taxonomy":"tx-product","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-product?post=100046"},{"taxonomy":"tx-pathology","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-pathology?post=100046"},{"taxonomy":"tx-content-type","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-content-type?post=100046"},{"taxonomy":"tx-active-ingredient","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-active-ingredient?post=100046"},{"taxonomy":"access","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/access?post=100046"},{"taxonomy":"user_status","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/user_status?post=100046"},{"taxonomy":"user_role","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/user_role?post=100046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}